Molina Healthcare Inc
Find Ratings ReportsMOLINA HEALTHCARE INC's gross profit margin for the fourth quarter of its fiscal year 2023 has decreased when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its subsector this quarter as compared to the same quarter a year ago. MOLINA HEALTHCARE INC has strong liquidity. Currently, the Quick Ratio is 1.50 which shows the ability to cover short-term cash needs. The company's liquidity has increased from the same period last year.
At the same time, stockholders' equity ("net worth") has greatly increased by 42.20% from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
Income Statement | Q4 FY23 | Q4 FY22 |
---|---|---|
Net Sales ($mil) | 9048.0 | 8223.0 |
EBITDA ($mil) | 400.0 | 386.0 |
EBIT ($mil) | 357.0 | 339.0 |
Net Income ($mil) | 216.0 | 56.0 |
Balance Sheet | Q4 FY23 | Q4 FY22 |
---|---|---|
Cash & Equiv. ($mil) | 9107.0 | 7505.0 |
Total Assets ($mil) | 14892.0 | 12314.0 |
Total Debt ($mil) | 2511.0 | 2531.0 |
Equity ($mil) | 4215.0 | 2964.0 |
Profitability | Q4 FY23 | Q4 FY22 |
---|---|---|
Gross Profit Margin | 11.52 | 12.21 |
EBITDA Margin | 4.42 | 4.69 |
Operating Margin | 3.95 | 4.12 |
Sales Turnover | 2.29 | 2.6 |
Return on Assets | 7.32 | 6.43 |
Return on Equity | 25.88 | 26.72 |
Debt | Q4 FY23 | Q4 FY22 |
---|---|---|
Current Ratio | 1.54 | 1.47 |
Debt/Capital | 0.37 | 0.46 |
Interest Expense | 27.0 | 27.0 |
Interest Coverage | 13.22 | 12.56 |
Share Data | Q4 FY23 | Q4 FY22 |
---|---|---|
Shares outstanding (mil) | 58.0 | 58.0 |
Div / share | 0.0 | 0.0 |
EPS | 3.7 | 0.96 |
Book value / share | 72.67 | 51.1 |
Institutional Own % | n/a | n/a |
Avg Daily Volume | 398586.0 | 382100.0 |
BUY. This stock's P/E ratio indicates a discount compared to an average of 21.84 for the Insurance Carriers and Related Activities subsector and a discount compared to the S&P 500 average of 27.95. To use another comparison, its price-to-book ratio of 5.60 indicates a premium versus the S&P 500 average of 4.68 and a significant premium versus the subsector average of 3.52. The price-to-sales ratio is well below both the S&P 500 average and the subsector average, indicating a discount. The valuation analysis reveals that, MOLINA HEALTHCARE INC seems to be trading at a discount to investment alternatives.
Price/Earnings |
|
Price/Cash Flow |
| |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MOH 21.65 | Peers 21.84 | MOH 14.19 | Peers 13.60 | |||||||||||||||||||||
Average. An average P/E ratio can signify an subsector neutral price for a stock and an average growth expectation. MOH is trading at a valuation on par with its peers. |
Average. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures. MOH is trading at a valuation on par to its peers. |
|||||||||||||||||||||||
Price/Projected Earnings |
|
Price to Earnings/Growth |
|
|||||||||||||||||||||
MOH 15.07 | Peers 14.42 | MOH 0.83 | Peers 0.87 | |||||||||||||||||||||
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations. MOH is trading at a premium to its peers. |
Average. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples. MOH trades at a valuation on par to its peers. |
|||||||||||||||||||||||
Price/Book |
|
Earnings Growth |
|
|||||||||||||||||||||
MOH 5.60 | Peers 3.52 | MOH 38.59 | Peers 95.58 | |||||||||||||||||||||
Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet. MOH is trading at a significant premium to its peers. |
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios. However, MOH is expected to significantly trail its peers on the basis of its earnings growth rate. |
|||||||||||||||||||||||
Price/Sales |
|
Sales Growth |
|
|||||||||||||||||||||
MOH 0.69 | Peers 1.96 | MOH 6.56 | Peers 37.25 | |||||||||||||||||||||
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales. MOH is trading at a significant discount to its subsector on this measurement. |
Lower. A sales growth rate that trails the subsector implies that a company is losing market share. MOH significantly trails its peers on the basis of sales growth. |
|||||||||||||||||||||||